These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9014458)

  • 1. [Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson's disease using 123I-iomazenil SPECT].
    Kawabata K; Tachibana H
    Nihon Rinsho; 1997 Jan; 55(1):244-8. PubMed ID: 9014458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
    Kawabata K; Tachibana H; Sugita M; Fukuchi M
    Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
    Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central benzodiazepine receptor distribution after subcortical hemorrhage evaluated by means of [123I]iomazenil and SPECT.
    Hatazawa J; Shimosegawa E; Satoh T; Kanno I; Uemura K
    Stroke; 1995 Dec; 26(12):2267-71. PubMed ID: 7491648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia.
    Verhoeff NP; Soares JC; D'Souza CD; Gil R; Degen K; Abi-Dargham A; Zoghbi SS; Fujita M; Rajeevan N; Seibyl JP; Krystal JH; van Dyck CH; Charney DS; Innis RB
    Psychiatry Res; 1999 Oct; 91(3):163-73. PubMed ID: 10641580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.
    Staley JK; Gottschalk C; Petrakis IL; Gueorguieva R; O'Malley S; Baldwin R; Jatlow P; Verhoeff NP; Perry E; Weinzimmer D; Frohlich E; Ruff E; van Dyck CH; Seibyl JP; Innis RB; Krystal JH
    Arch Gen Psychiatry; 2005 Aug; 62(8):877-88. PubMed ID: 16061765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders by 123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy by 123I-IMP].
    Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):41-6. PubMed ID: 9038062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography.
    Odano I; Anezaki T; Ohkubo M; Yonekura Y; Onishi Y; Inuzuka T; Takahashi M; Tsuji S
    Eur J Nucl Med; 1996 May; 23(5):598-604. PubMed ID: 8698070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
    Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion.
    al-Tikriti MS; Dey HM; Zoghbi SS; Baldwin RM; Zea-Ponce Y; Innis RB
    Eur J Nucl Med; 1994 Mar; 21(3):196-202. PubMed ID: 8200386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
    Pinborg LH; Videbaek C; Hasselbalch SG; Sørensen SA; Wagner A; Paulson OB; Knudsen GM
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):657-61. PubMed ID: 11309461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.
    Busatto GF; Pilowsky LS; Costa DC; Ell PJ; David AS; Lucey JV; Kerwin RW
    Am J Psychiatry; 1997 Jan; 154(1):56-63. PubMed ID: 8988959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of 123I-iomazenil SPECT in patients with ischemic cerebrovascular disease: comparative study with 123I-IMP SPECT].
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fujita M; Fukuchi K; Watanabe Y; Terakawa H; Uehara T; Nishimura T
    Kaku Igaku; 1996 Jun; 33(6):587-97. PubMed ID: 8741503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine receptor imaging with iomazenil SPECT in aphasic patients with cerebral infarction.
    Koshi Y; Kitamura S; Ohyama M; Komiyama T; Komaba Y; Sakayori O; Mishina M; Ishiwata A; Terashi A; Katayama Y
    Ann Nucl Med; 1999 Aug; 13(4):223-9. PubMed ID: 10510877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
    Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
    Kaku Igaku; 1996 Mar; 33(3):303-18. PubMed ID: 8622264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
    Makino K; Kamiyama H; Takamura H; Gotoh S; Kobayashi N
    Ann Nucl Med; 1999 Aug; 13(4):261-4. PubMed ID: 10510883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT.
    Tokunaga M; Ida I; Higuchi T; Mikuni M
    Radiat Med; 1997; 15(3):163-9. PubMed ID: 9278373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
    Verhoeff NP; Petroff OA; Hyder F; Zoghbi SS; Fujita M; Rajeevan N; Rothman DL; Seibyl JP; Mattson RH; Innis RB
    Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-iomazenil as a clinical tool for studying neuronal loss.
    Postiglione A; Soricelli ; Salvatore M; Lassen NA
    J Am Geriatr Soc; 1997 Apr; 45(4):534-6. PubMed ID: 9100734
    [No Abstract]   [Full Text] [Related]  

  • 20. 123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution.
    Haldemann RC; Bicik I; Pfeiffer A; Wieser HG; Hasler PH; Schubiger P; von Schulthess GK
    Nuklearmedizin; 1992 Jun; 31(3):91-7. PubMed ID: 1322533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.